Union Bancaire Privee UBP SA nearly doubled down on Marsh & McLennan, boosting its stake by an eyebrow-raising 139.8% in Q1.

Boston Scientific appears to be flexing a premium price tag that’s a bit too buff for its own balance sheet. Analysts using a ...

CVS Health is getting a healthy boost from institutional investors, with Parkside Investments increasing its stake by 36.7% in Q1. Parkside added over 20,000 shares, bringing its total to 76,084 ...

Mondelez International saw a tasty boost in investor confidence as Ferguson Wellman Capital upped its holdings by 31.2%, ...

Harbor Capital Advisors reduced its stake in Southwest Airlines by 22%, selling 2,563 shares during Q1, now holding 9,109 ...

Farther Finance Advisors isn’t just watching PayPal—they’re buying in, upping their stake by 95.6% to $1.01 million. This ...

Arete Research slapped Etsy with a “strong sell” rating, triggering investor panic and a 5.6% drop in share price. Other ...

Alibaba just got a shiny upgrade from Wall Street Zen, moving from “hold” to “buy”—because apparently, they finally found its ...

Palantir is riding high on AI buzz and investor dreams, with analyst Mark Schappel slapping a record $155 price target on it.

Bristol Myers' Sotyktu, a TYK2 inhibitor already approved for psoriasis, scored a win in a Phase III trial for psoriatic ...

Automatic Data Processing has fresh August 1st options that may entice both risk-takers and conservative investors. The $305 put option offers a possible 2.46% return if it expires worthless, with a ...

Milestone Asset Management slashed its NVIDIA holdings by 21.4% in Q1, reducing its stake to 54,236 shares worth $5.88 ...